Ivabradine and the SIGNIFY conundrum

John F. Beltrame
  • European Heart Journal, August 2015, European Society of Cardiology
  • DOI: 10.1093/eurheartj/ehv368

Ivabradine for Angina

Perspectives

Professor John F Beltrame
University of Adelaide

This editorial highlights the importance of identifying the mechanisms for the unexpected findings from the SIGNIFY trial.

Read Publication

http://dx.doi.org/10.1093/eurheartj/ehv368

The following have contributed to this page: Professor John F Beltrame

In partnership with: